106 related articles for article (PubMed ID: 9760298)
1. Effect of platelet activation on coronary collateral blood flow.
Kinn JW; Bache RJ
Circulation; 1998 Oct; 98(14):1431-7. PubMed ID: 9760298
[TBL] [Abstract][Full Text] [Related]
2. Intracoronary collagen: effects on coronary collateral circulation and the role of thromboxane.
Klassen CL; Bache RJ
J Cardiovasc Pharmacol; 2000 Jul; 36(1):90-5. PubMed ID: 10892665
[TBL] [Abstract][Full Text] [Related]
3. Effect of serotonin and thromboxane A2 on blood flow through moderately well developed coronary collateral vessels.
Wright L; Homans DC; Laxson DD; Dai XZ; Bache RJ
J Am Coll Cardiol; 1992 Mar; 19(3):687-93. PubMed ID: 1538028
[TBL] [Abstract][Full Text] [Related]
4. Constriction of canine coronary arteries by platelet activating factor after brief ischemia.
Kim YD; Danchak RM; Heim KF; Lees DE; Myers AK
Prostaglandins; 1993 Sep; 46(3):269-76. PubMed ID: 8234834
[TBL] [Abstract][Full Text] [Related]
5. The mechanism of coronary collateral vasoconstriction in response to cyclooxygenase blockade.
Altman JD; Bache RJ
Circ Res; 1994 Feb; 74(2):310-7. PubMed ID: 8293570
[TBL] [Abstract][Full Text] [Related]
6. Platelet-activating factor-induced coronary constriction in the isolated perfused guinea pig heart and antagonistic effects of the PAF antagonist WEB 2086.
Felix SB; Steger A; Baumann G; Busch R; Ochsenfeld G; Berdel WE
J Lipid Mediat; 1990; 2(1):9-20. PubMed ID: 2133268
[TBL] [Abstract][Full Text] [Related]
7. Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo. Thromboxane A2 and serotonin are possible mediators.
Golino P; Ashton JH; Buja LM; Rosolowsky M; Taylor AL; McNatt J; Campbell WB; Willerson JT
Circulation; 1989 Jan; 79(1):154-66. PubMed ID: 2910540
[TBL] [Abstract][Full Text] [Related]
8. Failure of nitroglycerin and diltiazem to reduce platelet-mediated vasoconstriction in dogs with coronary artery stenosis and endothelial injury: further evidence for thromboxane A2 and serotonin as mediators of coronary artery vasoconstriction in vivo.
Golino P; Buja LM; Yao SK; McNatt J; Willerson JT
J Am Coll Cardiol; 1990 Mar; 15(3):718-26. PubMed ID: 2105989
[TBL] [Abstract][Full Text] [Related]
9. Cyclic blood flow variations induced by platelet-activating factor in stenosed canine coronary arteries despite inhibition of thromboxane synthetase, serotonin receptors, and alpha-adrenergic receptors.
Apprill P; Schmitz JM; Campbell WB; Tilton G; Ashton J; Raheja S; Buja LM; Willerson JT
Circulation; 1985 Aug; 72(2):397-405. PubMed ID: 2988822
[TBL] [Abstract][Full Text] [Related]
10. Biphasic effects of platelet-activating factor on coronary blood flow in anesthetized dog.
Mehta J; Wargovich T; Nichols WW
Prostaglandins Leukot Med; 1986 Jan; 21(1):87-95. PubMed ID: 3456620
[TBL] [Abstract][Full Text] [Related]
11. Dose-dependent effect of endothelin-1 on blood flow to normal and collateral-dependent myocardium.
Traverse JH; Judd D; Bache RJ
Circulation; 1996 Feb; 93(3):558-66. PubMed ID: 8565176
[TBL] [Abstract][Full Text] [Related]
12. Effect of calcitonin gene-related peptide on well-developed canine coronary collateral vasculature.
Quebbeman BB; Dulas D; Altman J; Homans DC; Bache RJ
J Cardiovasc Pharmacol; 1993 May; 21(5):774-80. PubMed ID: 7685448
[TBL] [Abstract][Full Text] [Related]
13. Regulation of coronary blood flow during exercise.
Duncker DJ; Bache RJ
Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
[TBL] [Abstract][Full Text] [Related]
14. Role of thromboxane and serotonin as mediators in the development of spontaneous alterations in coronary blood flow and neointimal proliferation in canine models with chronic coronary artery stenoses and endothelial injury.
Willerson JT; Eidt JF; McNatt J; Yao SK; Golino P; Anderson HV; Buja LM
J Am Coll Cardiol; 1991 May; 17(6 Suppl B):101B-110B. PubMed ID: 2016468
[TBL] [Abstract][Full Text] [Related]
15. Effect of aspirin on coronary collateral blood flow.
Altman JD; Dulas D; Pavek T; Bache RJ
Circulation; 1993 Feb; 87(2):583-9. PubMed ID: 8425302
[TBL] [Abstract][Full Text] [Related]
16. Effect of thromboxane and serotonin receptor antagonists on intracoronary platelet deposition in dogs with experimentally stenosed coronary arteries.
Golino P; Buja LM; Ashton JH; Kulkarni P; Taylor A; Willerson JT
Circulation; 1988 Sep; 78(3):701-11. PubMed ID: 3409505
[TBL] [Abstract][Full Text] [Related]
17. Platelet-activating factor increases platelet-dependent glycoconjugate secretion from tracheal submucosal gland.
Sasaki T; Shimura S; Ikeda K; Sasaki H; Takishima T
Am J Physiol; 1989 Dec; 257(6 Pt 1):L373-8. PubMed ID: 2692465
[TBL] [Abstract][Full Text] [Related]
18. Mediation of reocclusion by thromboxane A2 and serotonin after thrombolysis with tissue-type plasminogen activator in a canine preparation of coronary thrombosis.
Golino P; Ashton JH; Glas-Greenwalt P; McNatt J; Buja LM; Willerson JT
Circulation; 1988 Mar; 77(3):678-84. PubMed ID: 3124975
[TBL] [Abstract][Full Text] [Related]
19. Endogenous adenosine and coronary vasoconstriction in hypoperfused myocardium during exercise.
Duncker DJ; Laxson DD; Lindstrom P; Bache RJ
Cardiovasc Res; 1993 Sep; 27(9):1592-7. PubMed ID: 8287435
[TBL] [Abstract][Full Text] [Related]
20. Involvement of platelet activating factor and thromboxane A2 in the renal response to unilateral ureteral obstruction.
Felsen D; Loo MH; Marion DN; Vaughan ED
J Urol; 1990 Jul; 144(1):141-5. PubMed ID: 2141654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
